Author/Authors :
Yuji Sobao، نويسنده , , Kazuhiro Sugi، نويسنده , , Hiroko Tomiyama، نويسنده , , Satoru Saito، نويسنده , , Shigetoshi Fujiyama، نويسنده , , Manabu Morimoto، نويسنده , , Satoru Hasuike، نويسنده , , Hirohito Tsubouchi، نويسنده , , Katsuaki Tanaka، نويسنده , , Masafumi Takiguchi، نويسنده ,
Abstract :
Background/Aims: The aim of this study was to identify and characterize hepatitis B virus (HBV)-specific cytotoxic T lymphocytes (CTL) epitopes presented by human leukocyte antigen (HLA)-A*2402, most common HLA class I allele in East Asia.
Methods: HLA-A*2402-restricted CTL epitopes were identified by reverse immunogenetics. Immunogenecity of these epitopes was investigated using peripheral blood mononuclear cell (PBMC) from HLA-A24+ patients with acute hepatitis B.
Results: An HLA-A*2402 stabilization assay demonstrated that 36 of 63 HBV peptides carrying HLA-A*2402 anchor residues have high- and medium-HLA-A*2402 binding affinity. Two (C117–125 and P756–764) of the 36 peptides induced peptide-specific CTLs. CTL clones and lines specific for these peptides killed HBV recombinant vaccinia virus-infected target cells expressing HLA-A*2402, indicating that these two peptides are CTL epitopes presented by HLA-A*2402. These two peptides were able to induce specific CTLs in 7 and 11 of 12 HLA-A24+ patients with acute hepatitis B, respectively.
Conclusions: We identified two immunodominant CTL epitopes restricted by HLA-A*2402. Because HLA-A*2402 is the most common allele in East Asia, a region in which there are approximately 200 million HBV carriers, these epitopes will be useful for analysis of CTL responses in patients from East Asia.